Usefulness of Abciximab for treatment of early coronary artery stent thrombosis

被引：19

作者：

Casserly, IP ^{[1
]}

Hasdai, D ^{[1
]}

Berger, PB ^{[1
]}

Holmes, DR ^{[1
]}

Schwartz, RS ^{[1
]}

Bell, MR ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Div Internal Med & Cardiovasc Dis, Rochester, MN 55905 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 82卷 / 08期

关键词：

D O I：

10.1016/S0002-9149(98)00519-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The clinical and angiographic outcomes of 10 patients who received abciximab as part of their therapy for early stent thrombosis was compared with 25 patients (using historical controls) who received conventional therapy. Although the angiographic outcome and the incidence of myocardial infarction in both groups was similar, there were no deaths or referral for emergency coronary bypass surgery in the abciximab-treated group versus 3 deaths and 10 referrals for emergency bypass surgery in the conventionally treated group.

引用

页码：981 / +

页数：6

共 16 条

[1] IN-VITRO MODEL TO TEST THE THROMBOGENICITY OF CORONARY STENTS [J].

BEYTHIEN, C ;

TERRES, W ;

HAMM, CW .

THROMBOSIS RESEARCH, 1994, 75 (06) :581-590

[2] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].

CALIFF, RM ;

SHADOFF, N ;

VALETT, N ;

BATES, E ;

GALEANA, A ;

KNOPF, W ;

SHAFTEL, J ;

BENDER, MJ ;

AVERSANO, T ;

RAQUENO, J ;

GURBEL, P ;

COWFER, J ;

COHEN, M ;

CROSS, P ;

BITTL, J ;

EDDINGS, K ;

TAYLOR, M ;

DEROSA, K ;

HATTEL, L ;

COOPER, L ;

ESHELMAN, B ;

FINTEL, D ;

NIEMYSKI, P ;

KLEIN, L ;

KENNEDY, H ;

THORNTON, T ;

KEREIAKES, D ;

MARTIN, L ;

ANDERSON, L ;

HIGBY, N ;

ELLIS, S ;

BREZINA, K ;

GEORGE, B ;

CHAPEKIS, A ;

SMITH, D ;

ANWAR, A ;

GERBER, TL ;

PRITCHARD, GL ;

MYLER, R ;

SHAW, R ;

MURPHY, M ;

WARD, K ;

MADIGAN, NP ;

BLANKENSHIP, J ;

HALBERT, M ;

FLANAGAN, C ;

TANNENBAUM, M ;

POLICH, M ;

STEVENSON, C ;

TCHENG, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961

[3] WIKTOR STENT IMPLANTATION IN PATIENTS WITH RESTENOSIS FOLLOWING BALLOON ANGIOPLASTY OF A NATIVE CORONARY-ARTERY [J].

DEJAEGERE, PP ;

SERRUYS, PW ;

BERTRAND, M ;

WIEGAND, V ;

KOBER, G ;

MARQUIS, JF ;

VALEIX, B ;

UEBIS, R ;

PIESSENS, J .

AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (06) :598-602

[4] THROMBOSIS AND RESTENOSIS AFTER STENTING IN FAILED ANGIOPLASTY - COMPARISON WITH ELECTIVE STENTING [J].

FOLEY, JB ;

BROWN, RIG ;

PENN, IM .

AMERICAN HEART JOURNAL, 1994, 128 (01) :12-20

[5] Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis [J].

Hasdai, D ;

Garratt, KN ;

Holmes, DR ;

Berger, PB ;

Schwartz, RS ;

Bell, MR .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (02) :361-367

[6] SUBACUTE THROMBOTIC COMPLICATIONS AFTER INTRACORONARY IMPLANTATION OF PALMAZ-SCHATZ STENTS [J].

HAUDE, M ;

ERBEL, R ;

ISSA, H ;

STRAUB, U ;

RUPPRECHT, HJ ;

TREESE, N ;

MEYER, J .

AMERICAN HEART JOURNAL, 1993, 126 (01) :15-22

[7]

Jeong MH, 1996, CATHETER CARDIO DIAG, V38, P38, DOI 10.1002/(SICI)1097-0304(199605)38:1<38::AID-CCD9>3.0.CO

[8]

2-4

[9]

Kereiakes DJ, 1996, J AM COLL CARDIOL, V27, P536

[10] MECHANISMS OF DISEASE - PLATELET GLYCOPROTEIN IIB/IIIA RECEPTORS IN CARDIOVASCULAR MEDICINE [J].

LEFKOVITS, J ;

PLOW, EF ;

TOPOL, EJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) :1553-1559

← 1 2 →